Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind trial of 10 µg recombinant hepatitis B vaccine (Hansenula polymorpha) in healthy neonates
CTR20132472Phase 3Active
- Sponsor
- Hualan Biological Vaccine
- Start
- May 2014
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant hepatitis B vaccine Bio Farma in hepatitis B (HBV), sponsored by Hualan Biological Vaccine. Started May 2014; status: active.
02
Drugs
recombinant hepatitis B vaccine Bio Farma
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on CTR20132472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132472.